Leap Therapeutics Inc (NASDAQ:LPTX) price on Thursday, July 03, rose 1.18% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $0.29.
A look at the stock’s price movement, the close in the last trading session was $0.29, moving within a range at $0.2839 and $0.3067. The beta value (5-Year monthly) was -0.223. Turning to its 52-week performance, $4.79 and $0.22 were the 52-week high and 52-week low respectively. Overall, LPTX moved -21.35% over the past month.
Leap Therapeutics Inc’s market cap currently stands at around $12.07 million, with investors looking forward to this quarter’s earnings report slated for on 2025-May-13.
Turning to the stock’s technical picture we see that short term indicators suggest on average that LPTX is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
3 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 3 recommend LPTX as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
LPTX’s current price about -16.82% and -21.37% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 37.79, while 7-day volatility ratio is 13.20% and 12.39% in the 30-day chart. Further, Leap Therapeutics Inc (LPTX) has a beta value of -0.28. Analysts have given the company’s stock an average 52-week price target of $5.5, forecast between a low of $5.5 and high of $5.5. Looking at the price targets, the low is -1796.55% off current price level while to achieve the yearly target high, price needs to move -1796.55%. Nonetheless, investors will most likely welcome a -1796.55% jump to $5.5 which is the analysts’ median price.
If we refocus on Leap Therapeutics Inc (NASDAQ:LPTX), historical trading data shows that trading volumes averaged 6.18 over the past 10 days and 1.31 million over the past 3 months. The company’s latest data on shares outstanding shows there are 41.44 million shares.
The 25.81% of Leap Therapeutics Inc’s shares are in the hands of company insiders while institutional holders own 21.56% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 1.59 million on 2025-06-13, giving us a short ratio of 4.65. The data shows that as of 2025-06-13 short interest in Leap Therapeutics Inc (LPTX) stood at 451.99999999999994 of shares outstanding, with shares short falling to 1.89 million registered in 2025-05-15. Current price change has pushed the stock -84.42% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the LPTX stock continues to rise going into the next quarter.
